معرفی
Amanda Nash serves as an Assistant Professor in the Department of Bioengineering at Rice University, leading a research program focused on developing cell communication technologies to treat cancer, autoimmune diseases, and aging through clinical translation of immunomodulatory approaches.
Her academic credentials include:
- Ph.D. in Bioengineering, Rice University (2023)
- B.S. in Biomedical Engineering, University of Houston (2018)
Her research integrates immunoengineering, cell communication, drug delivery, molecular diagnostics, extracellular vesicles, and materials science to develop controlled immune modulation strategies. The Nash lab emphasizes clinical translation of immunomodulatory technologies, building on her doctoral work with Omid Veish on implantable cytokine factories for ovarian cancer treatment.
Professional recognition includes:
- 2023 Hershel M. Rich Invention Award Body
Dr. Nash has authored numerous peer-reviewed publications and patents in immunoengineering and drug delivery. Following her Ph.D., she worked as a management consultant at McKinsey and Company specializing in pharmaceutical and medtech business strategy before returning to academia.
The Nash lab operates at the intersection of engineering and immunology, developing diagnostic and therapeutic platforms with direct clinical application pathways.
